These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15124861

  • 21. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
    Urayama S, Kawakami A, Matsuoka N, Tsuboi M, Nakashima T, Kawabe Y, Koji T, Eguchi K.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):782-8. PubMed ID: 9367846
    [Abstract] [Full Text] [Related]

  • 22. Induction of CD4+ T cell apoptosis as a consequence of impaired cytoskeletal rearrangement in UVB-irradiated dendritic cells.
    Wachter T, Averbeck M, Hara H, Tesmann JP, Simon JC, Termeer CC, Denfeld RW.
    J Immunol; 2003 Jul 15; 171(2):776-82. PubMed ID: 12847245
    [Abstract] [Full Text] [Related]

  • 23. Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation.
    Singh RK, Varney ML, Buyukberber S, Ino K, Ageitos AG, Reed E, Tarantolo S, Talmadge JE.
    Cancer Res; 1999 Jul 01; 59(13):3107-11. PubMed ID: 10397252
    [Abstract] [Full Text] [Related]

  • 24. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.
    Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW.
    J Immunol; 1997 Jun 15; 158(12):5676-84. PubMed ID: 9190916
    [Abstract] [Full Text] [Related]

  • 25. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
    Büssing A, Stein GM, Pfüller U, Schietzel M.
    Anticancer Res; 1999 Jun 15; 19(3A):1785-90. PubMed ID: 10470116
    [Abstract] [Full Text] [Related]

  • 26. Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L.
    Buonocore S, Haddou NO, Moore F, Florquin S, Paulart F, Heirman C, Thielemans K, Goldman M, Flamand V.
    J Leukoc Biol; 2008 Sep 15; 84(3):713-20. PubMed ID: 18567840
    [Abstract] [Full Text] [Related]

  • 27. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene.
    Pérez-Díez A, Butterfield LH, Li L, Chakraborty NG, Economou JS, Mukherji B.
    Cancer Res; 1998 Dec 01; 58(23):5305-9. PubMed ID: 9850054
    [Abstract] [Full Text] [Related]

  • 28. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R, Panka DJ, Wang JK, Stanger BZ, Ju ST, Marshak-Rothstein A.
    J Immunol; 1995 May 01; 154(9):4302-8. PubMed ID: 7536768
    [Abstract] [Full Text] [Related]

  • 29. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.
    Malowany JI, McCormick S, Santosuosso M, Zhang X, Aoki N, Ngai P, Wang J, Leitch J, Bramson J, Wan Y, Xing Z.
    Mol Ther; 2006 Apr 01; 13(4):766-75. PubMed ID: 16343993
    [Abstract] [Full Text] [Related]

  • 30. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
    Schwarz A, Grabbe S, Grosse-Heitmeyer K, Roters B, Riemann H, Luger TA, Trinchieri G, Schwarz T.
    J Immunol; 1998 May 01; 160(9):4262-70. PubMed ID: 9574528
    [Abstract] [Full Text] [Related]

  • 31. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L, Radrizzani M, Accornero P, Squarcina P, Chiodoni C, Mazzocchi A, Castelli C, Tarsini P, Viggiano V, Belli F, Colombo MP, Parmiani G.
    J Immunol; 1998 Aug 01; 161(3):1220-30. PubMed ID: 9686582
    [Abstract] [Full Text] [Related]

  • 32. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A, Pestano GA, Cantor H.
    J Immunol; 1998 Jan 15; 160(2):559-65. PubMed ID: 9551888
    [Abstract] [Full Text] [Related]

  • 33. TRANCE counteracts FasL-mediated apoptosis of murine bone marrow-derived dendritic cells.
    Chen A, Xu H, Choi Y, Wang B, Zheng G.
    Cell Immunol; 2004 Jan 15; 231(1-2):40-8. PubMed ID: 15919368
    [Abstract] [Full Text] [Related]

  • 34. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
    Han WG, Schuurhuis DH, Fu N, Camps M, van Duivenvoorde LM, Louis-Plence P, Franken KL, Huizinga TW, Melief CJ, Toes RE, Ossendorp F.
    Eur J Immunol; 2009 Jul 15; 39(7):1765-73. PubMed ID: 19544486
    [Abstract] [Full Text] [Related]

  • 35. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.
    Muppidi JR, Siegel RM.
    Nat Immunol; 2004 Feb 15; 5(2):182-9. PubMed ID: 14745445
    [Abstract] [Full Text] [Related]

  • 36. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH, Kang TH, Noh KH, Bae HC, Kim SH, Yoo YD, Seong SY, Kim TW.
    Immunol Lett; 2009 Jan 29; 122(1):58-67. PubMed ID: 19135479
    [Abstract] [Full Text] [Related]

  • 37. Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.
    Arimoto-Miyamoto K, Kadowaki N, Kitawaki T, Iwata S, Morimoto C, Uchiyama T.
    Immunology; 2010 May 29; 130(1):137-49. PubMed ID: 20201989
    [Abstract] [Full Text] [Related]

  • 38. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive.
    Kim SH, Bianco N, Menon R, Lechman ER, Shufesky WJ, Morelli AE, Robbins PD.
    Mol Ther; 2006 Feb 29; 13(2):289-300. PubMed ID: 16275099
    [Abstract] [Full Text] [Related]

  • 39. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
    Mukai T, Maeda Y, Tamura T, Matsuoka M, Tsukamoto Y, Makino M.
    J Immunol; 2009 Nov 15; 183(10):6561-8. PubMed ID: 19846882
    [Abstract] [Full Text] [Related]

  • 40. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells.
    Desbarats J, Duke RC, Newell MK.
    Nat Med; 1998 Dec 15; 4(12):1377-82. PubMed ID: 9846574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.